Singleron Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Singleron Biotechnologies's estimated annual revenue is currently $14.3M per year.
- Singleron Biotechnologies's estimated revenue per employee is $155,000
Employee Data
- Singleron Biotechnologies has 92 Employees.
- Singleron Biotechnologies grew their employee count by -12% last year.
Singleron Biotechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $36.9M | 238 | 9% | N/A | N/A |
#2 | $33.7M | 174 | -10% | $521.9M | N/A |
#3 | $52.4M | 338 | 15% | N/A | N/A |
#4 | $162.7M | 1219 | 33% | N/A | N/A |
#5 | $43.2M | 279 | 7% | N/A | N/A |
#6 | $1.1M | 7 | N/A | N/A | N/A |
#7 | $24.2M | 156 | 10% | N/A | N/A |
#8 | $19.7M | 127 | 8% | N/A | N/A |
#9 | $21.2M | 137 | 12% | $347.1M | N/A |
#10 | $18.3M | 118 | 7% | $197.4M | N/A |
What Is Singleron Biotechnologies?
Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking single cell analysis technologies to clinical diagnosis, drug development, and health management. The company was incorporated in January 2018 and currently has offices and laboratories in China, US, and Germany. Contact: info@singleronbio.com
keywords:N/A
N/A
Total Funding
92
Number of Employees
$14.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Singleron Biotechnologies News
Chinese genomics company Singleron Biotechnologies has acquired Proteona Pte. Ltd, a Singapore-based precision medicine company offering single-...
For instance, in November 2021, Singleron Biotechnologies, ... Also, the U.S. led global VC investment in biotech sector in 2020,...
Founded in 2018, Singleron develops and commercializes single-cell multiomics products, including instruments, microfluidic devices, reagents,...
Other Companies in Cologne
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.3M | 92 | -12% | N/A |
#2 | $14.3M | 92 | -12% | N/A |
#3 | $14.1M | 97 | -25% | N/A |
#4 | $25M | 100 | 0% | N/A |
#5 | N/A | 106 | 8% | N/A |